Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |